• Please log in or register to access this feature.

BRIEF REPORTS

Refractory Symptoms Successfully Treated with Leukotriene Inhibition in a Child with Systemic Mastocytosis

  1. PAUL J. TURNER F.R.A.C.P.1,2,
  2. ANDREW S. KEMP F.R.A.C.P.1,
  3. MAUREEN ROGERS F.R.A.C.P.3,
  4. SAM MEHR F.R.A.C.P.1

Article first published online: 2 NOV 2011

DOI: 10.1111/j.1525-1470.2011.01576.x

Issue

Pediatric Dermatology

Pediatric Dermatology

Volume 29, Issue 2, pages 222–223, March/April 2012

Additional Information

How to Cite

TURNER, P. J., KEMP, A. S., ROGERS, M. and MEHR, S. (2012), Refractory Symptoms Successfully Treated with Leukotriene Inhibition in a Child with Systemic Mastocytosis. Pediatric Dermatology, 29: 222–223. doi: 10.1111/j.1525-1470.2011.01576.x

Author Information

  1. 1

    Department of Allergy and Immunology, Children’s Hospital at Westmead, Sydney, Australia

  2. 2

    Discipline of Paediatrics and Child Health, School of Medicine, University of Sydney, Sydney, Australia

  3. 3

    Department of Dermatology, Children’s Hospital at Westmead, Sydney, Australia

*Address correspondence to Sam Mehr, F.R.A.C.P., Department of Allergy and Immunology, Children’s Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia, or e-mail: SamM@chw.edu.au.

Publication History

  1. Issue published online: 13 MAR 2012
  2. Article first published online: 2 NOV 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (67K)

Abstract:  Montelukast was effective in treating refractory abdominal and urinary symptoms in a child with systemic mastocytosis.

View Full Article (HTML) Get PDF (67K)